These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2108912)

  • 1. 1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor.
    Muhm M; Grois N; Kier P; Stümpflen A; Kyrle P; Pabinger I; Bettelheim P; Hinterberger W; Lechner K
    Haemostasis; 1990; 20(1):15-20. PubMed ID: 2108912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor to factor VIII in a non-haemophilic patient: evaluation of the response to DDAVP and the in vitro kinetics of factor VIII. A case report.
    Chistolini A; Ghirardini A; Tirindelli MC; Moretti T; Mancini F; Di Paolantonio T; Mariani G
    Nouv Rev Fr Hematol (1978); 1987; 29(4):221-4. PubMed ID: 3122176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 1-deamino 8 D-arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitor.
    de la Fuente B; Panek S; Hoyer LW
    Br J Haematol; 1985 Jan; 59(1):127-31. PubMed ID: 3918556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP in a non-haemophiliac patient with an acquired factor VIII inhibitor.
    Vincente V; Alberca I; Gonzalez R; Lopez Borrasca A
    Br J Haematol; 1985 Jul; 60(3):585-6. PubMed ID: 3925984
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1-deamino-8-D-arginine vasopressin on the prolonged bleeding time in chronic renal failure.
    Watson AJ; Keogh JA
    Nephron; 1982; 32(1):49-52. PubMed ID: 6817151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness, specificity and safety of intranasal 1-deamino-8-D-arginine vasopressin treatment of normal blood donors.
    Palmer DS; Harris AS; Tittley P; Rock G
    Haemostasis; 1988; 18(3):187-96. PubMed ID: 2972594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDAVP in acquired hemophilia A: case report and review of the literature.
    Mudad R; Kane WH
    Am J Hematol; 1993 Aug; 43(4):295-9. PubMed ID: 8372811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on blood coagulation in patients with hemophilia A and in healthy men].
    Blättler W; Jacky E; Müller M; Graf M
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1367-8. PubMed ID: 314661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal DDAVP: biological and clinical evaluation in mild factor VIII deficiency.
    Chistolini A; Dragoni F; Ferrari A; La Verde G; Arcieri R; Ege Mohamud A; Mazzucconi MG
    Haemostasis; 1991; 21(5):273-7. PubMed ID: 1806455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous injection of desmopressin (DDAVP): evaluation of a new, more concentrated preparation.
    Köhler M; Hellstern P; Tarrach H; Bambauer R; Wenzel E; Jutzler GA
    Haemostasis; 1989; 19(1):38-44. PubMed ID: 2493411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII-related activities after 1-deamino-8-D-arginine vasopressin in multicentric reticulohistiocytosis.
    Taddeo U; Trotta F; Menegale G; Ballerini G
    Ric Clin Lab; 1984; 14(1):37-9. PubMed ID: 6427880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dental management of patients with spontaneous acquired factor VIII inhibitors.
    Hasson DM; Poole AE; de la Fuente B; Hoyer LW
    J Am Dent Assoc; 1986 Oct; 113(4):633-6. PubMed ID: 2945852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
    Brenner B; Seligsohn U; Hochberg Z
    J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders.
    Mannucci PM
    Blood; 1988 Nov; 72(5):1449-55. PubMed ID: 3052622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.
    Mansouritorghabeh H; Shirdel A
    J Thromb Haemost; 2016 Feb; 14(2):336-9. PubMed ID: 26599105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in the treatment of mild hemophilia. Liberation of factor VIII from the vascular endothelium with 1-desamino-8-D-arginine vasopressin].
    Tjønnfjord GE; Evensen SA; Stormorken H; Trebo S
    Tidsskr Nor Laegeforen; 1989 Apr; 109(12):1291-2. PubMed ID: 2499950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DDAVP and its effect on factor VIII activity (author's transl)].
    Sikorová J; Vorlová Z
    Cas Lek Cesk; 1981 May; 120(18):553-6. PubMed ID: 6794913
    [No Abstract]   [Full Text] [Related]  

  • 19. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
    Santiago-Borrero PJ; Casanova R
    Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDAVP stimulates prostacyclin production.
    Belch JJ; Small M; McKenzie F; Hill PA; Lowe GD; McIntyre DE; Forbes CD; Prentice CR
    Thromb Haemost; 1982 Apr; 47(2):122-3. PubMed ID: 6808693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.